Stock listing
CHM Stock Price, News, Filings & Events — Chimeric Therapeutics Limited
Selected listing: CHM · ASX · AUD · AU
CHM:ASX is the public listing for Chimeric Therapeutics Limited, a company dedicated to developing innovative therapies in cell and gene therapy. With a market capitalization of approximately AUD 1.94 million, Chimeric Therapeutics is focused on addressing significant unmet medical needs through its advanced research and development efforts. The company is actively involved in the biotechnology sector, working on cutting-edge solutions to improve patient outcomes. Recent news and filings may provide further insights into their ongoing projects and market positioning.
- Ticker
- CHM:ASX
- Asset type
- Stock
- Market cap
- $1.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
Chimeric Therapeutics Limited CHM:ASX stock context
CHM:ASX is the public listing for Chimeric Therapeutics Limited, a company dedicated to developing innovative therapies in cell and gene therapy. With a market capitalization of approximately AUD 1.94 million, Chimeric Therapeutics is focused on addressing significant unmet medical needs through its advanced research and development efforts. The company is actively involved in the biotechnology sector, working on cutting-edge solutions to improve patient outcomes. Recent news and filings may provide further insights into their ongoing projects and market positioning.
Research Chimeric Therapeutics Limited
Chimeric Therapeutics Limited investor report
Review AI stock analysis and investor report context for CHM:ASX.
Chimeric Therapeutics Limited company profile
View the public company page for Chimeric Therapeutics Limited on 6ix.
Chimeric Therapeutics Limited news
Read company news and market updates connected to Chimeric Therapeutics Limited.
Chimeric Therapeutics Limited investor events
Find investor webinars, events, and replay context for Chimeric Therapeutics Limited.